JIM CROTTY
Portrait of Jim Crotty
Law Enforcement · Intelligence · Drug Policy

Jim Crotty

A global thought leader and subject matter expert in law enforcement, intelligence, transnational organized crime, and drug policy — with over 12 years of service at the U.S. Drug Enforcement Administration and a distinguished record of public service, academic scholarship, and policy advocacy.

Education
University of Alabama School of Law
JD · 2008
Boston College
MA, Political Science · 2005
Auburn University
BA, Political Science · 2003 · summa cum laude
Research Areas
Drug Policy · Transnational Organized Crime · Global Drug Trends · Money Laundering · Law Enforcement · Cyber & Online Drug Trafficking
Profile

Global Thought Leader in Law Enforcement & Drug Policy

Jim Crotty is a recognized subject matter expert in law enforcement, intelligence, transnational organized crime, and drug policy. He currently serves as Law Enforcement Outreach Manager at Meta Platforms, Inc., where he develops and maintains strategic relationships with law enforcement agencies across North America to help combat online criminal activity and prevent real-world harm.

Before joining Meta, Jim led the Investigative Support Section at the DC Metropolitan Police Department (MPD), managing a team of Criminal Research Specialists providing real-time intelligence on major crimes across the District of Columbia. He also served as Associate Vice President at The Cohen Group, a strategic advisory firm founded by former Secretary of Defense William Cohen, where he led client teams across defense, cybersecurity, healthcare, energy, and national security.

Jim’s distinguished public service career includes over 12 years with the U.S. Drug Enforcement Administration (DEA), serving in strategic, tactical, and operational positions domestically and internationally. His final DEA assignment was as Deputy Chief of Staff and Executive Assistant to the Administrator — the agency’s top leadership position.

He is an Adjunct Professor at American University’s School of Public Affairs, teaching courses on Drugs, Crime, and Public Policy. His commentary and analysis have been featured in the Washington Post, Wall Street Journal, Newsweek, The Hill, STAT News, The Guardian, and many other leading publications.

Career

Professional Experience

2024 – Present

Law Enforcement Outreach Manager

Meta Platforms, Inc. · Washington, D.C.

Develops and maintains strategic relationships with law enforcement agencies across North America to help combat online criminal activity and prevent real-world harm.

2024 – Present

Adjunct Professor / Lecturer

American University, School of Public Affairs · Washington, D.C.

Teaches JLC-451: Drugs, Crime & Public Policy and JLC-313: Organized Crime in the Department of Justice, Law & Criminology.

2023 – 2024

Lead, Investigative Support Section

DC Metropolitan Police Department (MPD) · Washington, D.C.

Led a team of Criminal Research Specialists providing real-time intelligence on major crimes across the District of Columbia.

2021 – 2023

Associate Vice President

The Cohen Group · Washington, D.C.

Led multiple client teams across defense, cybersecurity, healthcare, energy, and national security sectors at the strategic advisory firm founded by former Secretary of Defense William Cohen.

2009 – 2021

Deputy Chief of Staff & Multiple Roles

U.S. Drug Enforcement Administration (DEA) · Washington, D.C. · Chicago · London · Afghanistan

Over 12 years of distinguished service. Final role: Deputy Chief of Staff and Executive Assistant to the Administrator. Prior roles included Group Supervisor (Chicago Field Division), Liaison Officer (London Country Office, 2013–2018), Tactical Intelligence Analyst with FAST-Alpha (Afghanistan, 2010), and Strategic Intelligence Analyst focused on South America.

Pre-2009

Associate, National Security Practice

PRTM Management Consultants · Washington, D.C.

Provided strategic and operational advice to clients in the Intelligence Community, Department of Homeland Security, and Department of Defense.

Writing & Commentary

Selected Publications & Op-Eds

2026 · The Hill

Despite fewer deaths, the US is actually seeing more overdoses

Written with Madeline Hilliard. Argues that the decline in overdose deaths masks a record rise in nonfatal overdoses — evidence that the crisis is shifting shape rather than ending, and that fewer deaths should not be mistaken for success.

Read on The Hill →
2026 · International Journal of Drug Policy

Supply matters: What the sudden drop in overdose deaths reveals about the drug crisis

A peer-reviewed analysis of the recent sharp decline in U.S. overdose deaths, examining what the drop reveals about the role of drug supply in driving the crisis — and what it means for policy going forward.

Read in the International Journal of Drug Policy →
2026 · The Hill

The quiet resurgence of plant-based illicit drugs

Argues that despite the dominance of synthetic drugs, plant-based substances like cocaine and cannabis are quietly regaining market share, driven by the economics of the illicit drug trade.

Read on The Hill →
2026 · Small Wars Journal

Operation Absolute Resolve: A Rendition Revival?

Analyzes the Trump administration’s use of military renditions to extradite cartel leaders, questioning whether this controversial tactic can meaningfully reduce drug trafficking into the U.S.

Read on Small Wars Journal →
2025 · STAT News

What if pharma companies made ‘safe’ recreational drugs?

Explores the provocative idea of pharmaceutical companies producing regulated recreational drugs as an alternative to dangerous illicit substances, weighing public health benefits against regulatory and moral risks.

Read on STAT News →
2025 · Small Wars Journal

The New Militarized War on Drugs — Time to View Cartels as National Security Threats?

Makes the case for formally designating major drug cartels as national security threats, arguing that their power, violence, and geopolitical reach demand a military-grade strategic response.

Read on Small Wars Journal →
2025 · The Hill

‘Narconomics,’ not prohibition, is behind the rise in synthetic drugs

Contends that the explosion of synthetic drugs is driven by market economics — low production costs and high profit margins — not the failure of prohibition, requiring economic rather than purely punitive policy responses.

Read on The Hill →
2025 · Small Wars Journal / El Centro

Could Illicit Drug Production Shift to US?

Warns that tightening border enforcement and tariffs on Mexico could incentivize drug trafficking organizations to shift synthetic drug manufacturing operations to within the United States.

Read on Small Wars Journal →
2024 · The Hill

Overdose deaths are down, but the crisis is far from resolved

Cautions against complacency as overdose death numbers decline, arguing that the underlying structural drivers of the drug crisis — including supply chains and addiction — remain largely unaddressed.

Read on The Hill →
Video Appearances

On Camera

Fox News · August 26, 2022

Overdoses: Narcan Vending Machines Are the Latest Weapon Against Opioid Overdoses

Jim Crotty, former DEA Deputy Chief of Staff, weighs in on the proliferation of Narcan vending machines as a harm-reduction strategy, arguing that while keeping people alive is important, the ultimate goal must be ending drug use.

“We should be carpet-bombing the country with Narcan. But the goal can’t simply be to keep people alive — the goal has to be to stop doing drugs.”
Watch on Fox News →
Scripps News · 2024

To Save a Life: A National Fentanyl Alarm

Jim Crotty appears as a featured expert in this Scripps News documentary on the fentanyl crisis, tracing the origins of the epidemic from prescription drug over-marketing through the heroin wave to the current synthetic drug catastrophe.

“The drug trade is a profit-driven enterprise. The lethality of fentanyl is a calculated risk for dealers — and that’s what makes it so dangerous.”
Watch the documentary →
Media Coverage

In the News

“We’re seeing this decrease in overdose deaths and everyone’s still trying to suss out exactly why. I don’t think now is the time that we want to stop any of those existing efforts because we know that at least some, or a combination of them, have been working.”The Guardian — “Trump policies could fuel illicit drug trade despite vow to curb fentanyl” · March 8, 2025 · By Hannah Harris Green. Crotty criticized Trump’s tariffs on Mexico, Canada, and China as ‘coercive,’ warning they could disrupt existing anti-drug efforts and undermine intelligence-sharing partnerships.
“If it were an athlete, people would call it ‘The G.O.A.T.’ It is in fact the most pernicious, the most devastating drug that we have ever seen.”Wall Street Journal — “How Two Mexican Drug Cartels Came to Dominate America’s Fentanyl Supply” · August 30, 2022 · By Jon Kamp, José de Córdoba & Julie Wernau
“The goal can’t simply be to keep people alive. If you believe, like me, that doing drugs is very destructive, then the goal has to be to stop doing drugs.”Associated Press — “A look inside the 1st official ‘safe injection sites’ in US” · March 9, 2022 · By Jennifer Peltz
“Potential exposure to these substances is still quite small, thank goodness. When you use hyperbole, you can actually lose the audience and the message.”STAT News — “Fentanyl busts saved 258 million lives? Experts say that’s implausible” · May 7, 2025 · By Lev Facher. Crotty pushed back on Attorney General Pam Bondi’s claim that Trump-era drug busts saved 258 million lives.
Affiliations

Professional Affiliations & Fellowships

United Against Fentanyl

Advisory Board Member

Bipartisan non-profit focused on ending the U.S. opioid crisis.

End Overdose

Drug Policy Advisor

National nonprofit working to prevent drug overdose deaths through naloxone access, education, and community training.

Team Awareness Combating Overdose (TACO)

Faculty Advisor

Student-led overdose-prevention nonprofit bringing harm-reduction education to college campuses; faculty advisor through American University.

Global Initiative Against Transnational Organized Crime (GI-TOC)

Network of Experts Member

International network of researchers and practitioners addressing organized crime.

USF Global and National Security Institute (GNSI)

Non-Resident Senior Fellow

University of South Florida research institute on national security.

Small Wars Journal – El Centro

2026 Fellow / Associate

Leading journal on irregular warfare and national security strategy.

Center for Advanced Defense Studies (C4ADS)

Former Senior Fellow

Supported Organized Crime and Grand Corruption team on drug trafficking and money laundering.

Presidential Management Fellows Program

Former Fellow

Prestigious U.S. government leadership development program.

International Society for the Study of Drug Policy (ISSDP)

Member

International network of scholars and practitioners dedicated to rigorous, evidence-based drug policy research.

Connect

Connect with Jim

LinkedIn Profile American University Profile

Email: [email protected]

↑